Jiangsu Nhwa Pharmaceutical Co., LTD (SHE: 002262)
China
· Delayed Price · Currency is CNY
26.65
+0.65 (2.50%)
Nov 15, 2024, 10:34 AM CST
Jiangsu Nhwa Pharmaceutical Co., LTD Company Description
Jiangsu Nhwa Pharmaceutical Co., LTD engages in research and development, production, marketing, and services related to central nervous system drugs in China and internationally.
The company’s products are used for treatment of anesthesia, analgesia, mental and neurological diseases, narcotic, psychiatry, and neurological categories, as well as APIs.
It sells its products through hospitals, private hospitals, online pharmacies, and chain pharmacies. The company was founded in 1978 and is headquartered in Xuzhou, China.
Jiangsu Nhwa Pharmaceutical Co., LTD
Country | China |
Founded | 1978 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 5,394 |
CEO | Jiaquan Sun |
Contact Details
Address: Enhua Technology Building Xuzhou, Jiangsu Province 221009 China | |
Website | nhwa-group.com |
Stock Details
Ticker Symbol | 002262 |
Exchange | Shenzhen Stock Exchange |
Fiscal Year | January - December |
Reporting Currency | CNY |
ISIN Number | CNE100000CG8 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Jiaquan Sun | GM and Non-Independent Director |
Gangsheng Li | Chief Financial Officer |
Qing Fu | Deputy GM and Non-Independent Director |
Zengliang Chen | Deputy GM and Non-Independent Director |
Ziliang Yang | Deputy GM and Non-Independent Director |
Bao Zhou Duan | Deputy GM and Secretary |